What lab tests are used to diagnose hypothyroidism?
What are normal/hypo/hyper levels of TSH?
How long after initiation of treatment for hypothyroidism would you recheck labs?
Check TSH 6-8 weeks after initiating therapy and after any dosage change
What are the signs and symptoms of hypothyroidism?
What are the signs and symptoms of and hyperthyroidism?
How is a thyroid storm treated?
Using a combination of:
Can be a result of not treating hypothyroidism during pregnancy.
What medication is used to treat symptoms of hyperthyroidism?
These are antithyroid drugs which treat the symptoms but not the condition itself.
What medications reduce absorption of levothyroxine?
What drugs accelerate metabolism of levothyroxine?
How do you confirm a diagnosis of diabetes?
What are the general goals for a1c when treating diabetics?
General goal: < 7%
Older Adult goal: < 8%
In what situations should insulin be used for treatment?
How often should an A1C be checked after beginning treatment for diabetes?
Every three months until it is less or equal to 7%
Then every 6 months thereafter
Name three actions of insulin
What are contraindications for pioglitazone?
GLP-1
Glucagon-like peptide-1 receptor agonists
TZD
Thiazolidinediones
DPP4-I
Dipeptidyl peptidase 4 Inhibitors
SGLT2i
Sodium-glucose Cotransporter 2 Inhibitors
Which drug class should be considered for diabetes prior to insulin?
Biguanides
Mechanism of action for GLP-1
Glucogon like peptide (non insulin injectable)
Augments the effects of the incretin hormone GLP-1 by:
Thereby reducing glucose levels and inducing weight loss.
Mechanism of Action for TZD
Thiazolidinediones
Reduce glucose levels by decreasing insulin resistance
Activation of a PPAR receptor which turns on insulin-responsive genes resulting in:
- increased cellular uptake of glucose by the skeletal muscle and adipose cells
(Enhances response to insulin, therefore insulin needs to be present for the drug to work)
MOA for DPP-4i
Dipeptidyl peptidase 4 Inhibitors
Enhances the action of incretin hormones to:
Sulfonylureas
Stimulating the release of insulin from pancreatic islets (not for DM1) by binding with and blocking ATP sensitive potassium channels int eh cell membrane. The membrane then depolarizes permitting a Ca influx causing a release of insulin.